2023, Vol. 3, Issue 2, Part A
Development and validation of new discriminative dissolution method for Prucalopride tabletsAuthor(s):
Prapti J Desai, Priya Chidrewar and Arun SatheAbstract:
In order to cater to the developed market, it is necessary to have a specific dissolve process that can be used for quality control testing and product assessment in quality by design trials. The present work showcases the methodical creation of a dissolving technique that allows for discrimination of the BCS Class 2 medication Prucalopride Tablets. It is worth noting that the solubility of this medicine is significantly influenced by pH levels. Concurrently, the pH, velocity, and equipment were tuned and subjected to testing in order to assess the method's robustness, repeatability, and variability. The method's ability to discriminate was appropriately proved.Pages: 38-45 | Views: 51 | Downloads: 17Download Full Article: Click Here
How to cite this article:
Prapti J Desai, Priya Chidrewar, Arun Sathe. Development and validation of new discriminative dissolution method for Prucalopride tablets. Int J Pharm Sci Drug Anal 2023;3(2):38-45.